Literature DB >> 29468340

Phrasing of the patient global assessment in the rheumatoid arthritis ACR/EULAR remission criteria: an analysis of 967 patients from two databases of early and established rheumatoid arthritis patients.

Laure Gossec1,2, John Richard Kirwan3,4,5, Maarten de Wit3,4,6,7, Andra Balanescu3,4,8, Cecile Gaujoux-Viala3,4,9,10, Francis Guillemin3,4, Anne-Christine Rat3,4,11, Alain Saraux3,4,12,13, Bruno Fautrel3,4, Tore K Kvien3,4,14, Maxime Dougados3,4,15.   

Abstract

The ACR/EULAR Boolean remission criteria for rheumatoid arthritis (RA) include a strict cutoff for patient global assessment (PGA, value ≤ 1/10). Near-remission corresponds to remission for joint counts and C-reactive protein but with PGA > 1. The objective was to explore whether the contribution of PGA to remission and near-remission varied according to the wording of the PGA and in relation to disease duration. In patients with early arthritis (N = 731, French ESPOIR cohort) or established RA (N = 236 patients from across Europe), frequency of remission versus near-remission was assessed according to the phrasing used for PGA (global health versus disease activity). In 967 patients (mean [standard deviation] age 49.7 [12.7] years, 76.7% women), remission was infrequent: range 12.9-16.7% (according to wording of PGA) in early RA and 6.8-7.2% in established RA. Near-remission was more frequent: 13.0-16.8% in early RA and 13.1-13.6% in established RA. The ratio of remission to near-remission was higher in the early arthritis cohort (0.8-1.3 versus 0.5-0.5 in established RA). Using the disease activity PGA led to more remission and less near-remission than the global health PGA in the early arthritis cohort (12.9 vs 16.7% near-remission, respectively, p = 0.047) but not in established RA. The proportion of patients who can be classified as remission or near-remission differs in early RA compared to establish RA and depends upon the formulation of the PGA question. PGA referring to disease activity and not global health may be preferred in early disease, if the objective is more alignment with inflammation assessment.

Entities:  

Keywords:  Outcome measures; Pain; Patient-reported outcome measures; Quality of life; Remission; Rheumatoid arthritis

Mesh:

Year:  2018        PMID: 29468340     DOI: 10.1007/s10067-018-3998-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  20 in total

1.  Psychological state is related to the remission of the Boolean-based definition of patient global assessment in patients with rheumatoid arthritis.

Authors:  Mie Fusama; Yasushi Miura; Kumiko Yukioka; Takanori Kuroiwa; Chikako Yukioka; Miyako Inoue; Tae Nakanishi; Norikazu Murata; Noriko Takai; Kayoko Higashi; Taro Kuritani; Keiji Maeda; Hajime Sano; Masao Yukioka; Hideko Nakahara
Journal:  Mod Rheumatol       Date:  2015-07-20       Impact factor: 3.023

2.  Patient's global assessment of disease activity and patient's assessment of general health for rheumatoid arthritis activity assessment: are they equivalent?

Authors:  Nasim Ahmed Khan; Horace Jack Spencer; Essam Ahmed Abda; Rieke Alten; Christof Pohl; Codrina Ancuta; Massimiliano Cazzato; Pál Géher; Laure Gossec; Dan Henrohn; Merete Lund Hetland; Nevsun Inanc; Johannes Wg Jacobs; Eduardo Kerzberg; Maria Majdan; Omondi Oyoo; Ruben A Peredo-Wende; Zahraa Ibrahim Selim; Fotini Nikolaos Skopouli; Alberto Sulli; Kim Hørslev-Petersen; Peter C Taylor; Tuulikki Sokka
Journal:  Ann Rheum Dis       Date:  2012-04-24       Impact factor: 19.103

3.  Remission of rheumatoid arthritis in clinical practice: application of the American College of Rheumatology/European League Against Rheumatism 2011 remission criteria.

Authors:  Shadi H Shahouri; Kaleb Michaud; Ted R Mikuls; Liron Caplan; Timothy S Shaver; James D Anderson; David N Weidensaul; Ruth E Busch; Shirley Wang; Frederick Wolfe
Journal:  Arthritis Rheum       Date:  2011-11

4.  Near misses of ACR/EULAR criteria for remission: effects of patient global assessment in Boolean and index-based definitions.

Authors:  Paul Studenic; Josef S Smolen; Daniel Aletaha
Journal:  Ann Rheum Dis       Date:  2012-06-26       Impact factor: 19.103

Review 5.  Early lessons from the recent-onset rheumatoid arthritis cohort ESPOIR.

Authors:  Bernard Combe; Nathalie Rincheval
Journal:  Joint Bone Spine       Date:  2014-09-17       Impact factor: 4.929

Review 6.  The Reporting of Patient-reported Outcomes in Studies of Patients with Rheumatoid Arthritis: A Systematic Review of 250 Articles.

Authors:  Levent Kilic; Abdulsamet Erden; Clifton O Bingham; Laure Gossec; Umut Kalyoncu
Journal:  J Rheumatol       Date:  2016-04-15       Impact factor: 4.666

7.  Updating the OMERACT filter: implications for patient-reported outcomes.

Authors:  John R Kirwan; Susan J Bartlett; Dorcas E Beaton; Maarten Boers; Ailsa Bosworth; Peter M Brooks; Ernest Choy; Maarten de Wit; Francis Guillemin; Sarah Hewlett; Tore K Kvien; Robert B Landewé; Amye L Leong; Anne Lyddiatt; Lyn March; James May; Pamela Lesley Montie; Enkeleida Nikaï; Pam Richards; Marieke M J H Voshaar; Wilma Smeets; Vibeke Strand; Peter Tugwell; Laure Gossec
Journal:  J Rheumatol       Date:  2014-03-01       Impact factor: 4.666

8.  The patient perspective on remission in rheumatoid arthritis: 'You've got limits, but you're back to being you again'.

Authors:  Lilian H D van Tuyl; Sarah Hewlett; Martina Sadlonova; Bev Davis; Caroline Flurey; Wijnanda Hoogland; John Kirwan; Tessa Sanderson; Dirkjan van Schaardenburg; Marieke Scholte-Voshaar; Josef Smolen; Tanja Stamm; Maarten Boers
Journal:  Ann Rheum Dis       Date:  2014-02-12       Impact factor: 19.103

Review 9.  Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature.

Authors:  Elena Nikiphorou; Helga Radner; Katerina Chatzidionysiou; Carole Desthieux; Codruta Zabalan; Yvonne van Eijk-Hustings; William G Dixon; Kimme L Hyrich; Johan Askling; Laure Gossec
Journal:  Arthritis Res Ther       Date:  2016-10-28       Impact factor: 5.156

10.  Comparison of remission criteria in a tumour necrosis factor inhibitor treated rheumatoid arthritis longitudinal cohort: patient global health is a confounder.

Authors:  Emese Balogh; Joao Madruga Dias; Carl Orr; Ronan Mullan; Len Harty; Oliver FitzGerald; Phil Gallagher; Miriam Molloy; Eileen O'Flynn; Alexia Kelly; Patricia Minnock; Madeline O'Neill; Louise Moore; Mairead Murray; Ursula Fearon; Douglas J Veale
Journal:  Arthritis Res Ther       Date:  2013-12-24       Impact factor: 5.156

View more
  2 in total

1.  Remission or Not Remission, That's the Question: Shedding Light on Remission and the Impact of Objective and Subjective Measures Reflecting Disease Activity in Rheumatoid Arthritis.

Authors:  Alen Brkic; Katarzyna Łosińska; Are Hugo Pripp; Mariusz Korkosz; Glenn Haugeberg
Journal:  Rheumatol Ther       Date:  2022-09-21

2.  Limiting factors to Boolean remission differ between autoantibody-positive and -negative patients in early rheumatoid arthritis.

Authors:  Serena Bugatti; Ludovico De Stefano; Antonio Manzo; Garifallia Sakellariou; Blerina Xoxi; Carlomaurizio Montecucco
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-05-22       Impact factor: 5.346

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.